摘要:
The present invention relates to probiotic Propionibacterium strains and their use in the preparation of probiotic supplements and foods. The invention relates to the provision of Vitamin B 12 , propionic acid, folacin and bacteriocins by probiotic strains, stimulation of bifidobacteria growth, production of favourable effects on the lipid metabolism and on the immune system of hosts through immunostimulation, immunomodulation or use of a probiotic strain as an adjuvant, reduction of homocysteine and beta glucuronidase and the prevention, treatment or amelioration of conditions associated with a need for these activities. The probiotic bacteria of the invention can be used in humans or other animals. In at least some applications, the bacteria can be used dead and parts rather than whole cells may be used. The present invention also relates to the preparation of vaccines for use in protecting patients from infectious diseases, in particular tuberculosis.
摘要:
PROBLEM TO BE SOLVED: To disclose compounds and methods for inducing protective immunity against tuberculosis. SOLUTION: The compounds provided include polypeptides that contain at least one immunogenic portion of one or more M. tuberculosis proteins, and DNA molecules encoding such polypeptides. The compounds can be formulated into vaccines and/or pharmacological compositions against M. tuberculosis infection, or can be used for diagnosis of tuberculosis. COPYRIGHT: (C)2009,JPO&INPIT
摘要:
PROBLEM TO BE SOLVED: To provide a cytotoxic factor which stimulates cell death by necrosis or apoptosis. SOLUTION: The present invention provides a use of a truncated azurin for preparing a pharmaceutical composition for increasing cell death of a cancer cell wherein the truncated azurin is at least one compound that is cytotoxic by an ATP-dependent mechanism, and is the one obtained from pathogenic bacteria secreting at least one compound which is cytotoxic by the ATP-nondependent mechanism. COPYRIGHT: (C)2009,JPO&INPIT